Tic disorder

Postpartum Support International Urges Friends, Family to Check on New and Expectant Moms this May

Retrieved on: 
Monday, May 1, 2023

PORTLAND, Ore., May 1, 2023 /PRNewswire/ -- May brings National Maternal Mental Health Month and Mother's Day, making it an ideal time to educate mothers and the people in their lives about postpartum depression and other perinatal mental health (PMH) disorders. Nonprofit Postpartum Support International (PSI) is working to improve PMH disorder awareness and access to support and care while reducing stigma around perinatal mental health disorders. 

Key Points: 
  • Nonprofit Postpartum Support International (PSI) is working to improve PMH disorder awareness and access to support and care while reducing stigma around perinatal mental health disorders.
  • Although postpartum depression is commonly cited, other PMH disorders include anxiety, obsessive-compulsive disorder, post-traumatic stress disorder, bipolar disorder, and psychosis.
  • Moms and their partners should know support and care are available, and you don't need a diagnosis to get help.
  • Laundry, cooking or ordering takeout, and watching the baby so she can have time alone are all ways to provide support.

Bend Health's Digital Measurement-Based Care Significantly Reduces Anxiety and Depression Symptoms in Children and Adolescents

Retrieved on: 
Thursday, April 20, 2023

MADISON, Wis., April 20, 2023 /PRNewswire/ -- Bend Health, Inc. ("Bend"), a national provider of pediatric mental health care services for children and families, today announced its digital, measurement-based collaborative care model significantly reduced anxiety and depression symptoms in children and adolescents, according to a new study published in JMIR Pediatrics and Parenting.

Key Points: 
  • ("Bend"), a national provider of pediatric mental health care services for children and families, today announced its digital, measurement-based collaborative care model significantly reduced anxiety and depression symptoms in children and adolescents, according to a new study published in JMIR Pediatrics and Parenting.
  • Digital measurement-based care significantly improves symptoms of anxiety and depression in children and adolescents.
  • Among 114 patients with elevated anxiety and depressive symptoms, 73.3% with anxiety symptoms and 73.1% with depressive symptoms showed improvement.
  • "Digital measurement-based care significantly improves symptoms of anxiety and depression in children and adolescents," said Dr. Monika Roots, Bend co-founder and president.

Increasing Stress Could Lead to Eating Disorders in College Students According to Alsana

Retrieved on: 
Wednesday, April 19, 2023

A recent Gallup and Lumina poll found that 41% of college students have considered pausing their studies due to increased stress within the last six months.

Key Points: 
  • A recent Gallup and Lumina poll found that 41% of college students have considered pausing their studies due to increased stress within the last six months.
  • Experts from Alsana note that stress can contribute to the development of eating disorders, which occurs in 10-20% of college women and 4-10% of men .
  • It’s important that parents know how to identify an eating disorder in college students as May Mental Health Awareness Month approaches, along with high school graduates preparing to head off to colleges in the fall.
  • Virtual programs, such as Alsana Connect , allow students to remain in school during treatment.

From Trump to Winnie the Pooh: how we use diagnosis as a narrative tool to make sense of dysfunction and deviance

Retrieved on: 
Monday, April 17, 2023

Being diagnosed with COVID makes sense of symptoms, determines what we should do about them, and shapes our collective responsibility to the community.

Key Points: 
  • Being diagnosed with COVID makes sense of symptoms, determines what we should do about them, and shapes our collective responsibility to the community.
  • You have symptoms, the doctor examines or tests you, you get a name for what ails you.
  • Even a diagnosis as seemingly clear-cut as COVID is more than just a label stuck to a virus.
  • Read more:
    COVID testing led to new techniques of disease diagnosis: progress mustn’t stop now

Diagnosis as storytelling

    • Diagnosis is so important to understanding our lives and those around us that it’s often applied outside of the health setting.
    • TV shows such as House use diagnostic mysteries to underpin plots – less Whodunit and more Whatisit.
    • A diagnosis is a story, in and of itself.
    • You have an infection of your lungs, probably caused by bacteria or a virus and possibly triggered by that cold you had last week.

Stories and deviance

    • Diagnostic stories are explanations of deviance.
    • By “deviance” we mean the sociological sense of the term: an inability to meet social expectations of behaviour, belief or experience.
    • To explain deviance, we often defer to diagnosis.
    • More than 150 scientific authors have thrown themselves at finding a diagnosis to explain his deviance.

Medicalising experiences

    • These stories say more about us, the diagnosers, and our contemporary views, than the lives of those they seek to describe.
    • By using diagnosis to explain people, we medicalise our experience of the world and shut down other avenues of explanation.
    • Just as explaining an imaginary character via diagnosis means we’ve lost faith in stories.

Addex Publishes Dipraglurant Data Showing In Vivo Efficacy on Motor and Non-Motor Symptoms of Parkinson’s Disease

Retrieved on: 
Tuesday, April 4, 2023

Dipraglurant is an mGlu5 negative allosteric modulator (NAM) that has successfully completed a Phase 2a study in Parkinson’s disease patients suffering from levodopa induced dyskinesia (PD-LID).

Key Points: 
  • Dipraglurant is an mGlu5 negative allosteric modulator (NAM) that has successfully completed a Phase 2a study in Parkinson’s disease patients suffering from levodopa induced dyskinesia (PD-LID).
  • “For some time, we have known that excessive glutamate activity from degeneration of the nigro-striatal dopamine pathway has played a key role in the negative impact of motor symptoms, NMS and dyskinesias in PD patients.
  • In the current study, published in Cells , the effects of dipraglurant were investigated in a rodent motor symptoms model of PD, as well as anxiety, depression and obsessive-compulsive disorder, all of which are among the most prevalent NMS symptoms.
  • “We are now evaluating the best and most efficient way forward with the future development of dipraglurant in multiple potential therapeutic applications.”

Relief Mental Health expands services in Milwaukee area with transcranial magnetic stimulation for smoking addiction

Retrieved on: 
Thursday, April 6, 2023

Relief Mental Health , an outpatient provider of transcranial magnetic stimulation (TMS), psychedelic therapy (SPRAVATO® esketamine), psychiatric medication management, and talk therapy, has added smoking addiction treatment in its West Allis location with cutting-edge BrainsWay Deep TMS technology.

Key Points: 
  • Relief Mental Health , an outpatient provider of transcranial magnetic stimulation (TMS), psychedelic therapy (SPRAVATO® esketamine), psychiatric medication management, and talk therapy, has added smoking addiction treatment in its West Allis location with cutting-edge BrainsWay Deep TMS technology.
  • It uses electromagnetic pulses to stimulate neurons in parts of the brain, reducing tobacco cravings and increasing cognitive control.
  • According to the CDC , smoking leads to disease and disability and harms nearly every organ of the body.
  • “Most adult cigarette smokers want to quit but have trouble doing so on their own,” said Susan Mueller, founder and CEO of Relief Mental Health.

Integrating and Building Lives - From Homelessness to Self-Sufficiency - April 20, 2023, 8:00-10:00 AM CT- Six Organizations - Reimaging our Pathways

Retrieved on: 
Wednesday, April 12, 2023

Six organizations are addressing the pathways and a call to action of the homeless and defining supportive and sustainable measures to self-sufficiency again.

Key Points: 
  • Six organizations are addressing the pathways and a call to action of the homeless and defining supportive and sustainable measures to self-sufficiency again.
  • More details and to register>
    Some call for reimagining the current model of care for people experiencing homelessness.
  • Still, others call for attention with substance abuse disorders, opioids, behavioral health issues, job insecurity, and lack of safe housing to prevent or address homelessness.
  • Regardless of its origins, we live in a world where homelessness is a humanitarian crisis that touches most communities.

Bend Health Expands Access to Improved Pediatric and Teen Mental Health Care

Retrieved on: 
Thursday, March 23, 2023

MADISON, Wis., March 23, 2023 /PRNewswire/ --Bend Health, Inc. ("Bend") a leading national, virtual pediatric behavioral care provider, today announced that it has expanded access to its services through agreements with two of the nation's largest health insurers, employers totaling 650,000 people, and integrated medical and behavioral health partnerships with Sauk Prairie Healthcare, Allegro Pediatrics, and other multi-specialty systems with 500 doctors and care providers nationwide.

Key Points: 
  • These agreements, along with growing health system and employer partnerships and self-pay, extend Bend access to all 50 states and the District of Columbia.
  • "As a mom and child psychiatrist, it's deeply concerning to me that our communities, families, and health system are ill-equipped to support positive mental health development and care," said Dr. Monika Roots, Bend co-founder and president.
  • "We started Bend because we believe there is a better way that enables access to preventative services in mental health care like we have in primary care today, while also ensuring emergency service support.
  • "This is meaningful progress, and everyone across health care must continue working together to address our national mental health care crisis.

Cure Rare Disease Welcomes Leading Experts to Scientific Advisory Board

Retrieved on: 
Monday, March 20, 2023

As part of their role, SAB members help advance CRD's preclinical and clinical development of its gene therapy and antisense oligonucleotide (ASO) programs, providing strategic advice on scientific, regulatory, and clinical matters.

Key Points: 
  • As part of their role, SAB members help advance CRD's preclinical and clinical development of its gene therapy and antisense oligonucleotide (ASO) programs, providing strategic advice on scientific, regulatory, and clinical matters.
  • The members of the newly appointed SAB bring a wealth of expertise and experience in the areas of treatment and therapeutic development for neuromuscular diseases.
  • "Their insights and guidance will be critical as we continue to advance our programs and work towards our goal of providing life-saving treatments to individuals with rare diseases."
  • Collectively, these programs offer pragmatic hope of treatment to more than 200,000 Americans living with rare and ultra-rare diseases.

BrainsWay Reports Fourth Quarter and Full-Year 2022 Financial Results and Operational Highlights

Retrieved on: 
Wednesday, March 15, 2023

and JERUSALEM, March 15, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a world leader in advanced and non-invasive treatment for brain disorders, today reported fourth quarter and full-year 2022 financial results and provided an operational update.

Key Points: 
  • and JERUSALEM, March 15, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a world leader in advanced and non-invasive treatment for brain disorders, today reported fourth quarter and full-year 2022 financial results and provided an operational update.
  • Gross margin for the fourth quarter of 2022 was 71%, compared to 77% for the fourth quarter 2021.
  • Operating expenses for the fourth quarter of 2022 totaled $8.6 million, compared to $8.0 million for the fourth quarter of 2021.
  • Operating loss for the fourth quarter of 2022 was $4.3 million, compared to a loss of $1.5 million for the same period in 2021.